News & Events
News, industry insights and noteworthy events.
At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.
For media or press inquiries, please email us.Contact Us
Proveca and Tanner Pharma initiate global Managed Access Program for Sialanar®
For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 firstname.lastname@example.org CHARLOTTE, N.C. – Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. Sialanar is for the treatment of sialorrhea, or chronic drooling, in…Read More
Tanner Pharma Group Signs Exclusive Distribution Agreement with Merz North America for Named Patient Sales of Cuvposa® (glycopyrrolate) oral solution into Emerging Markets
New access for children in Latin American markets with neurologic conditions that cause chronic severe drooling Tanner Pharma Group, a global provider of integrated specialty access solutions, announces the signing of an exclusive distribution agreement with Merz North America, a specialty healthcare company with a strong commitment to the U.S. neurosciences space. The agreement names…Read More